Close Menu

NEW YORK –Progenity announced today it has acquired Medimetrics' patent portfolio for ingestible device technologies.

Financial terms of the agreement were not disclosed.

Medimetrics, based in the Netherlands, is an ingestible device company with 137 granted patents and 15 pending patent applications in the US, Europe, China, and Japan.

Following the purchase, San Diego-based Progenity will own 200 granted patents and 216 pending applications.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.